CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 2015—Corgenix Medical has received U.S. FDA emergency use authorization for its ReÂEBOV Antigen Rapid Test. The test is to be used for the presumptive detection of Ebola Zaire virus in individuals with signs and symptoms of Ebola virus infection in conjunction with epidemiological risk factors, including geographic locations with high prevalence of Ebola infection.
Read More »